The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States-Reference-Cited by-同舟云学术

The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States

Published:2020-11 Issue:5 Volume:223 Page:721.e1-721.e18
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Mandelbaum Rachel S.,Adams Crystal L.,Yoshihara Kosuke,Nusbaum David J.,Matsuzaki Shinya,Matsushima Kazuhide,Klar Maximilian,Paulson Richard J.,Roman Lynda D.,Wright Jason D.,Matsuo Koji^ORCID

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology

Reference46 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

2. Carcinoma of the ovaries and fallopian tubes;Coleman,2019

3. Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer;Walker;Cancer,2015

4. Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer;Piek;J Pathol,2001

5. Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol;Rabban;Am J Surg Pathol,2009

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating sojourn time and sensitivity of screening for ovarian cancer using a Bayesian framework;JNCI: Journal of the National Cancer Institute;2024-07-23

2. Bilateral Oophorectomy Prevalence Among U.S. Women;Journal of Women's Health;2024-07-16

3. Novel Cancer Prevention Strategies in Individuals With Hereditary Cancer Syndromes: Focus on BRCA1, BRCA2, and Lynch Syndrome;American Society of Clinical Oncology Educational Book;2024-06

4. Diagnosis Shift in Site of Origin of Tubo-Ovarian Carcinoma;Obstetrics & Gynecology;2024-03-21

5. Serous tubal intraepithelial carcinoma (STIC) outcomes in an average risk population;Gynecologic Oncology Reports;2024-02